# US 2013/0273155 A1 · Prebiotic Compositions for use with Probiotics to increase probiotic growth rate and activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0273155 A1
- Document ID: US20130273155A1
- Status: Published application
- Kind: A1
- Application number: 13/905,197
- Filed: 2013-05-30
- Published: 2013-10-17
- Earliest claimed: 2010-07-09
- Assignees: Master Supplements, Inc.
- Inventors: Sonja Lea Yonak; Randolph S. Porubcan
- Web page: https://patentgrep.com/patent/US20130273155A1

## CPC

- A61K 31/66: Phosphorus compounds
- A61K 31/201: having one or two double bonds, e.g. oleic, linoleic acids
- A61K 31/685: one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A61K 35/745: Bifidobacteria
- A61K 35/747: Lactobacilli, e.g. L. acidophilus or L. brevis
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 1/10: Laxatives
- A61P 1/12: Antidiarrhoeals
- A61P 1/14: Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 31/10: Antimycotics
- Y10S 435/853: Lactobacillus
- Y10S 435/854: Lactobacillus acidophilus
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of Lactobacillus and Bifidobacterium species of probiotic bacteria, and replace polysorbate 80 for those products. They can be used in naturally occurring form, or where they are to be combined with probiotics in a carrier, or they can be treated to yield a stable powdered form of these naturally oily compounds. They can be sold as combined prebiotic/probiotic formulations in the same carrier, or sold as separate dietary supplements, e.g., in capsule or tablet form, to be used with the probiotic formulation as desired.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A method of treating diarrhea, vaginal yeast infections, constipation, heartburn, bloating, indigestion, flatulence or poor nutrient absorption, comprising:
administering a formulation of a dry powdered form of probiotic bacteria including Lactobacillus or Bifidobacterium; and
administering a formulation of a dry powdered form of a prebiotic formulation including sunflower lecithin or oleic acid, or combinations of sunflower lecithin and oleic acid.

### Claim 25 (depends on 24)

The method of claim 24 wherein the prebiotic formulation is adsorbed to one or more of calcium silicate, silicon dioxide, silica, clays and food starches, and mixed with microcrystalline cellulose and silica.

### Claim 26 (depends on 24)

The method of claim 24 wherein the lecithin or oleic acid, or the combinations of lecithin and oleic acid, are non-aqueous.

### Claim 27 (depends on 24)

The method of claim 24 wherein the lecithin or oleic acid, or the combinations of lecithin and oleic acid, are in a capsule, caplet, tablet or other carrier together with Lactobacillus and/or Bifidobacterium species.

### Claim 28 (depends on 24)

The method of claim 24 wherein prebiotic formulation is administered separately from the Lactobacillus or Bifidobacterium species.

### Claim 29 (depends on 28)

The method of claim 28 wherein prebiotic formulation is administered before or after the probiotic bacteria.

### Claim 30 (depends on 24)

The method of claim 24 wherein the lecithin is soy lecithin or sunflower lecithin.

### Claim 31 (depends on 24)

The method of claim 24 wherein the probiotic formulation includes Lactobacillus, Bifidobacterium and other probiotic strains.

### Claim 32 (depends on 31)

The method of claim 31 wherein the strains of Lactobacillus include Lactobacillus acidophilus NCFM, Lactobacillus rhamnosus Lr-32, Lactobacillus paracasei Lpc-37, and Lactobacillus salavarius Ls-33.

### Claim 33 (depends on 31)

The method of claim 31 wherein the Bifidobacterium is Bifidobacterium lactis Bl-04 (BL-34).

### Claim 34 (depends on 25)

The method of claim 25 wherein the food starches are corn starch or potato starch.

### Claim 35 (depends on 25)

The method of claim 25 wherein the clays are food grade.

### Claim 36 (depends on 25)

The method of claim 25 wherein the clays are kaolin or sodium bentonite.

### Claim 37 (depends on 25)

The method of claim 25 wherein the lecithin is sunflower lecithin or soy lecithin, and including oleic acid.

### Claim 38 (depends on 37)

The method of claim 37 wherein the lecithin is sunflower lecithin and the ratio of sunflower lecithin to oleic acid is 90:10.

### Claim 39 (depends on 29)

The method of claim 29 further including Vitamin E.

### Claim 40 (depends on 39)

The method of claim 39 wherein Vitamin E is the D, L or a mixture of the D and L isomers.

### Claim 41 (depends on 39)

The method of claim 39 wherein the Vitamin E is 0.05 to 2% by weight of the formulation.

### Claim 42 (depends on 27)

The method of claim 27 wherein the tablet, caplet, capsule or carrier has an enteric coating.

### Claim 43 (depends on 28)

The method of claim 28 wherein the prebiotic formulation is in a capsule or caplet.

### Claim 44 (depends on 43)

The method of claim 43 wherein the caplet or capsule has an enteric coating.

### Claim 45 (depends on 24)

The method of claim 24 wherein carbohydrates are administered with the lecithin or oleic acid, or with the combinations of lecithin and oleic acid.

### Claim 46 (depends on 45)

The method of claim 45 wherein 50 g of carbohydrate are administered with the lecithin or oleic acid, or with the combinations of lecithin and oleic acid.

### Claim 47 (depends on 24)

The method of claim 24 wherein 10 to 100 mg of the lecithin or oleic acid, or 10 to 100 mg of the combinations of lecithin and oleic acid, are administered for each dose of the Lactobacillus and/or Bifidobacterium.

### Claim 48 (depends on 47)

The method of claim 47 wherein 20 mg of the lecithin or oleic acid, or 20 mg of the combinations of lecithin and oleic acid, are administered for each dose of the Lactobacillus and/or Bifidobacterium.

### Claim 49 (depends on 24)

The method of claim 24 wherein the lecithin is sunflower lecithin and the formulation also includes oleic acid.
